Connective Tissue Diseases  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00295178: Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

Completed
4
80
US
Daptomycin, Vancomycin
Cubist Pharmaceuticals LLC
Cellulitis
08/06
08/06
NCT01549613: Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

Completed
4
104
US
Daptomycin, Vancomycin
University of Cincinnati
Cellulitis, Skin Infections
07/13
07/13
NCT01626560: The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Completed
4
20
RoW
Daptomycin, Vancomycin
Hospital Universitario Evangelico de Curitiba
Cellulitis
03/15
03/15

Download Options